Translating Precision Health for Pediatrics: A Scoping Review

Author:

Subasri Mathushan1,Cressman Celine1ORCID,Arje Danielle12,Schreyer Leighton1ORCID,Cooper Erin1,Patel Komal1,Ungar Wendy J.13ORCID,Barwick Melanie13ORCID,Denburg Avram134ORCID,Hayeems Robin Z.13ORCID

Affiliation:

1. Child Health Evaluative Sciences Program, The Hospital for Sick Children Research Institute, Toronto, ON M5G 1X8, Canada

2. Department of Paediatrics, University of Toronto, Toronto, ON M5G 1X8, Canada

3. Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, ON M5T 3M6, Canada

4. Division of Haematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, ON M5G 1X8, Canada

Abstract

Precision health aims to personalize treatment and prevention strategies based on individual genetic differences. While it has significantly improved healthcare for specific patient groups, broader translation faces challenges with evidence development, evidence appraisal, and implementation. These challenges are compounded in child health as existing methods fail to incorporate the physiology and socio-biology unique to childhood. This scoping review synthesizes the existing literature on evidence development, appraisal, prioritization, and implementation of precision child health. PubMed, Scopus, Web of Science, and Embase were searched. The included articles were related to pediatrics, precision health, and the translational pathway. Articles were excluded if they were too narrow in scope. In total, 74 articles identified challenges and solutions for putting pediatric precision health interventions into practice. The literature reinforced the unique attributes of children and their implications for study design and identified major themes for the value assessment of precision health interventions for children, including clinical benefit, cost-effectiveness, stakeholder values and preferences, and ethics and equity. Tackling these identified challenges will require developing international data networks and guidelines, re-thinking methods for value assessment, and broadening stakeholder support for the effective implementation of precision health within healthcare organizations. This research was funded by the SickKids Precision Child Health Catalyst Grant.

Funder

Precision Child Health Catalyst Grant

Canada Research Chair in Economic Evaluation and Technology Assessment in Child Health

Canada Research Chair in Genomics and Health Policy

Publisher

MDPI AG

Subject

Pediatrics, Perinatology and Child Health

Reference113 articles.

1. Towards precision medicine;Ashley;Nat. Rev. Genet.,2016

2. From CFTR biology toward combinatorial pharmacotherapy: Expanded classification of cystic fibrosis mutations;Veit;Mol. Biol. Cell,2016

3. Newborn screening for cystic fibrosis;Castellani;Lancet Respir. Med.,2016

4. A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy;Zaher;Cureus,2021

5. Translational precision medicine: An industry perspective;Hartl;J. Transl. Med.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3